Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
MOLECULAR PARTNERS AG (MOLN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. MOLN is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 5 institutional filers currently hold this stock. Top institutional holders of MOLN by reported 13-F value include SUVRETTA CAPITAL MANAGEMENT, BVF, CITADEL ADVISORS, based on the most recent SEC filings. MOLN trades on the Nasdaq exchange and files with the SEC under CIK 1745114. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MOLN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MOLECULAR PARTNERS AG directly from SEC EDGAR.
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2024 | 20-F | $5.0M | — | — |
| FY 2023 | 20-F | $7.0M | — | — |
| FY 2022 | 20-F | $189.6M | — | — |
| FY 2021 | 20-F | $9.8M | — | — |
| FY 2020 | 20-F | $9.3M | — | — |
| FY 2019 | 20-F | $20.4M | — | — |
| Institution | Shares | Value | Reported |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT | 2,221,494 | $8.6M | 2026-06-30 |
| BVF | 1,353,968 | $5.1M | 2026-06-30 |
| CITADEL ADVISORS | 17,179 | $65.3K | 2026-06-30 |
| MORGAN STANLEY | 367 | $1.4K | 2026-06-30 |
| UBS Group AG | 279 | $1.1K | 2026-06-30 |
13F Pro Quality Score
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 5 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Financial metrics will appear once SEC EDGAR data is ingested for this company.